We further established a correlation between the circulating tumor-reactive response and CD8 T cell tumor infiltration in HR+ breast tumors and showed that circulating tumor-reactive TCRs could be detected in the tumor-infiltrating T cells (TILs). The gene discussed is CD8A; the disease is neoplasm.